Old Web
English
Sign In
Acemap
>
authorDetail
>
M. Vander Lugt
M. Vander Lugt
University of Michigan
Immunology
Diabetes mellitus
Medicine
Biomarker (medicine)
Graft-versus-host disease
3
Papers
9
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Plasma Concentration of Suppressor of Tumorigenicity 2 (ST2), the IL33 Receptor, at Initiation of Graft Versus Host Disease Therapy Predicts Day 28 Response and Day 180 Survival Post-Treatment
2012
Biology of Blood and Marrow Transplantation
M. Vander Lugt
Thomas M. Braun
James L.M. Ferrara
Samir Hanash
John E. Levine
C.-H. Wang
Qing Zhang
Alice Chin
Andrew C. Harris
Sung Won Choi
Daniel R. Couriel
Pavan Reddy
Sophie Paczesny
Show All
Source
Cite
Save
Citations (1)
A Three Biomarker Panel at Days 7 and 14 Can Predict Development of Grade II-IV Acute Graft-Versus-Host Disease
2011
Biology of Blood and Marrow Transplantation
Sophie Paczesny
Thomas M. Braun
M. Vander Lugt
Andrew C. Harris
Bryan Fiema
J. Hernandez
Sung Won Choi
Carrie L. Kitko
John Magenau
G. Yanik
Edward Peres
Attaphol Pawarode
Shin Mineishi
Joel Whitfield
Dawn Jones
Daniel R. Couriel
R. Pavan
Samir Hanash
James L.M. Ferrara
John E. Levine
Show All
Source
Cite
Save
Citations (6)
1